VEGF‐C induced lymphangiogenesis is associated with lymph node metastasis in orthotopic MCF‐7 tumors
Open Access
- 8 February 2002
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 98 (6) , 946-951
- https://doi.org/10.1002/ijc.10283
Abstract
The spread of cancer cells to regional lymph nodes through the lymphatic system is the first step in the dissemination of breast cancer. In several human cancers including those of the breast and prostate, the expression of vascular endothelial growth factor C (VEGF‐C) is associated with lymph node metastasis. Our study was undertaken to evaluate the effect of VEGF‐C on metastasis of poorly invasive, estrogen dependent human MCF‐7 breast cancer cells. MCF‐7 breast cancer cells transfected with VEGF‐C (MCF‐7‐VEGF‐C) were grown as tumors in the mammary fat pads of nude mice implanted with subcutaneous estrogen pellets. Tumor lymphangiogenesis and lymph node metastasis were studied immunohistochemically using antibodies against lymphatic vessel hyaluronan receptor ‐1 (LYVE‐1), VEGF receptor‐3 (VEGFR‐3), PECAM‐1, pan‐cytokeratin and estrogen dependent pS2 protein. Overexpression of VEGF‐C in transfected MCF‐7 cells stimulated in vivo tumor growth in xenotransplanted mice without affecting estrogen responsiveness. The resulting tumors metastasized to the regional lymph nodes in 75% (in 6 mice out of 8, Experiment I) and in 62% (in 5 mice out of 8, Experiment II) of mice bearing orthotopic tumors formed by MCF‐7‐VEGF‐C cells whereas no metastases were observed in mice bearing tumors of control vector‐transfected MCF‐7 cells (MCF‐7‐Mock). The density of intratumoral and peritumoral lymphatic vessels was increased in tumors derived from MCF‐7‐VEGF‐C cells but not MCF‐7‐Mock cells. Taken together, our results show that VEGF‐C overexpression stimulates tumor lymphangiogenesis and induces normally poorly metastatic estrogen‐dependent MCF‐7 tumors to disseminate to local lymph nodes. These data suggest that VEGF‐C has an important role in lymph node metastasis of breast cancer even at its hormone‐dependent early stage.Keywords
Funding Information
- Academy of Finland
- European Commission
This publication has 30 references indexed in Scilit:
- Mouse LYVE-1 Is an Endocytic Receptor for Hyaluronan in Lymphatic EndotheliumJournal of Biological Chemistry, 2001
- Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasisOncogene, 2000
- VEGFR-3 and Its Ligand VEGF-C Are Associated with Angiogenesis in Breast CancerThe American Journal of Pathology, 1999
- Vascular Endothelial Growth Factors VEGF-B and VEGF-C Are Expressed in Human TumorsThe American Journal of Pathology, 1998
- Proinflammatory Cytokines Regulate Expression of the Lymphatic Endothelial Mitogen Vascular Endothelial Growth Factor-CJournal of Biological Chemistry, 1998
- Characterization of murine Flt4 ligand/VEGF-COncogene, 1997
- Hyperplasia of Lymphatic Vessels in VEGF-C Transgenic MiceScience, 1997
- Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxiaOncogene, 1997
- Apoptosis in Toremifene-Induced Growth Inhibition of Human Breast Cancer Cells In Vivo and In VitroJNCI Journal of the National Cancer Institute, 1993
- Biological differences among MCF-7 human breast cancer cell lines from different laboratoriesBreast Cancer Research and Treatment, 1987